0,585  0,026  15-Lipoxygenase inhibitor
0,491  0,035  5 Hydroxytryptamine release inhibitor
0,457  0,037  CYP2C19 inhibitor
0,406  0,027  Antineoplastic (glioblastoma multiforme)
0,434  0,058  Histamine release inhibitor
0,450  0,083  Caspase 9 stimulant
0,381  0,025  Pyruvate kinase inhibitor
0,391  0,038  Antineoplastic (glioma)
0,365  0,036  Antiprotozoal (Trypanosoma)
0,348  0,020  Antimutagenic
0,404  0,078  Antineoplastic (breast cancer)
0,364  0,039  CYP1A2 inhibitor
0,389  0,073  Antiprotozoal
0,353  0,047  Aryl hydrocarbon receptor agonist
0,350  0,051  CYP3A4 inhibitor
0,401  0,119  DNA polymerase beta inhibitor
0,395  0,117  DNA directed DNA polymerase inhibitor
0,352  0,079  Antineoplastic (lung cancer)
0,288  0,020  Tubulin antagonist
0,283  0,023  CYP2B6 inhibitor
0,338  0,088  Ulceration
0,371  0,123  MAP kinase 1 inhibitor
0,310  0,064  Aldehyde oxidase inhibitor
0,309  0,067  Lipoxygenase inhibitor
0,304  0,069  Antineoplastic (melanoma)
0,261  0,028  Antineoplastic (carcinoma)
0,306  0,074  Antimycobacterial
0,290  0,061  Antineoplastic (non-small cell lung cancer)
0,309  0,080  Vasodilator, coronary
0,293  0,068  Antituberculosic
0,294  0,069  Hypoxia-inducible factor 1 alpha inhibitor
0,227  0,003  Potassium channel Kv1.3 blocker
0,308  0,085  ICAM1 expression inhibitor
0,299  0,081  Antineoplastic (brain cancer)
0,309  0,097  Thioredoxin glutathione reductase inhibitor
0,268  0,058  Potassium channel blocker
0,219  0,012  Breast cancer-resistant protein inhibitor
0,321  0,116  TNF expression inhibitor
0,233  0,035  3C-like protease (Human coronavirus) inhibitor
0,339  0,145  Apoptosis agonist
0,243  0,050  VCAM1 expression inhibitor
0,205  0,012  Beta glucuronidase inhibitor
0,262  0,070  Antineoplastic (cervical cancer)
0,329  0,140  Transcription factor inhibitor
0,257  0,069  Antiprotozoal (Leishmania)
0,210  0,030  Carcinogenic, group 1
0,269  0,090  CYP2D6 inhibitor
0,212  0,034  Neuropathy treatment
0,274  0,097  Prostate cancer treatment
0,259  0,083  UGT2B4 substrate
0,187  0,016  Photosensitizer
0,321  0,150  Alpha-glucosidase inhibitor
0,290  0,123  GABA C receptor rho-3 antagonist
0,206  0,044  Cholinergic
0,202  0,040  MAO inhibitor
0,217  0,057  I kappa B kinase epsilon inhibitor
0,252  0,095  GST M1-1 substrate
0,265  0,109  Thyroid hormone beta antagonist
0,213  0,060  Focal adhesion kinase 2 inhibitor
0,192  0,039  Toll-Like receptor 9 antagonist
0,206  0,054  5 Hydroxytryptamine 3E antagonist
0,168  0,016  Carcinogenic, group 2A
0,204  0,053  Dual specificity phosphatase inhibitor
0,197  0,046  Muscular dystrophy treatment
0,155  0,005  Granulocyte macrophage colony stimulating factor agonist
0,268  0,119  Antileukemic
0,226  0,079  Cytostatic
0,209  0,065  DNA methyltransferase I inhibitor
0,218  0,074  Antimitotic
0,191  0,048  Antiviral (Hepatitis C)
0,259  0,118  Thyroid hormone antagonist
0,171  0,031  MAO B inhibitor
0,180  0,042  Skin whitener
0,209  0,073  DNA methylase inhibitor
0,197  0,062  Antiviral (Hepatitis)
0,232  0,099  Transcription factor STAT3 inhibitor
0,247  0,114  Caspase 3 stimulant
0,198  0,069  Mutagenic
0,197  0,069  CDC-like kinase 4 inhibitor
0,252  0,125  Prostaglandin dehydrogenase inhibitor
0,200  0,074  Pneumotoxic
0,170  0,044  Acetylcholinesterase inhibitor
0,140  0,018  Macrophage migration inhibitory factor inhibitor
0,185  0,070  Chemopreventive
0,234  0,119  12-Lipoxygenase inhibitor
0,215  0,104  Antineoplastic (sarcoma)
0,179  0,068  Tumour necrosis factor antagonist
0,212  0,102  Antineoplastic (renal cancer)
0,209  0,099  Antiviral (West Nile virus)
0,219  0,111  Antineoplastic (colon cancer)
0,241  0,134  Transcription factor NF kappa B inhibitor
0,140  0,034  Platelet activating factor alpha antagonist
0,219  0,113  Antineoplastic (pancreatic cancer)
0,223  0,118  Antineoplastic (colorectal cancer)
0,142  0,036  CC chemokine 6 receptor antagonist
0,163  0,058  GABA C receptor rho-2 antagonist
0,170  0,067  UGT2B10 substrate
0,128  0,025  Estrogen receptor beta antagonist
0,203  0,103  Antihypotensive
0,174  0,075  Succinate dehydrogenase inhibitor
0,106  0,008  Potassium channel intermediate-conductance Ca-activated blocker
0,219  0,124  Antineoplastic (multiple myeloma)
0,254  0,159  CYP2C9 inhibitor
0,246  0,152  Calcium channel activator
0,106  0,011  Aryl hydrocarbon receptor antagonist
0,146  0,052  Topoisomerase II inhibitor
0,102  0,012  Orexin receptor 1 antagonist
0,094  0,005  Inosine monophosphate dehydrogenase inhibitor
0,233  0,147  FMO1 substrate
0,176  0,094  Clk dual-specificity kinase inhibitor
0,126  0,044  Estrogen antagonist
0,096  0,014  Orexin receptor antagonist
0,154  0,074  Protein-tyrosine phosphatase inhibitor
0,152  0,072  CF transmembrane conductance regulator agonist
0,158  0,079  Arachidonic acid antagonist
0,165  0,086  Amyloid beta precursor protein antagonist
0,177  0,098  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,123  0,044  Acetylcholine release stimulant
0,219  0,143  AR expression inhibitor
0,160  0,087  Nitric oxide antagonist
0,113  0,043  Antifungal (Aspergillus)
0,096  0,027  Amidase inhibitor
0,180  0,112  Potassium channel (Voltage-sensitive) blocker
0,140  0,073  Mannose-6-phosphate isomerase inhibitor
0,187  0,121  RNA-directed DNA polymerase inhibitor
0,140  0,075  Vascular endothelial growth factor 3 antagonist
0,085  0,022  Glutamate (mGluR7) antagonist
0,122  0,059  Antifungal (Pneumocystis)
0,080  0,018  Fatty acid synthase inhibitor
0,078  0,016  Kallikrein 7 inhibitor
0,191  0,130  Antineoplastic (ovarian cancer)
0,169  0,108  Insulin sensitizer
0,120  0,061  Microtubule formation inhibitor
0,194  0,136  UGT1A9 substrate
0,157  0,099  Sedative
0,216  0,160  Antineoplastic (osteosarcoma)
0,094  0,039  CYP2A6 inhibitor
0,187  0,133  Superoxide dismutase inhibitor
0,095  0,041  Acetylcholine nicotinic agonist
0,235  0,181  Antipruritic, allergic
0,160  0,106  Sepsis treatment
0,089  0,036  Estrogen receptor alpha antagonist
0,180  0,129  Nitric-oxide synthase stimulant
0,133  0,083  UGT2B15 substrate
0,186  0,135  Radioprotector
0,159  0,111  Abortion inducer
0,166  0,119  Histone acetyltransferase inhibitor
0,119  0,073  DNA repair enzyme inhibitor
0,138  0,092  UGT2B9 substrate
0,107  0,062  Antiprotozoal (Toxoplasma)
0,068  0,025  Nicotinic alpha7 receptor agonist
0,206  0,164  CTGF expression inhibitor
0,108  0,065  Electron transport complex I inhibitor
0,121  0,079  Antibacterial (Helicobacter pylori)
0,089  0,047  D-Ala-D-Ala ligase inhibitor
0,073  0,033  Beta tubulin antagonist
0,187  0,146  5 Hydroxytryptamine 1E antagonist
0,236  0,197  Antiparkinsonian
0,167  0,129  NOS2 expression inhibitor
0,146  0,108  Cytotoxic
0,050  0,013  Orexin receptor 2 antagonist
0,207  0,171  Apoptosis antagonist
0,041  0,005  Inosine monophosphate dehydrogenase 2 inhibitor
0,119  0,084  Antihelmintic (Trematoda)
0,148  0,113  LDLR expression enhancer
0,103  0,068  Topoisomerase I inhibitor
0,083  0,049  NAD(P)H dehydrogenase (quinone) inhibitor
0,188  0,155  Transcription factor STAT inhibitor
0,144  0,111  Aldehyde oxidase substrate
0,198  0,166  Cholesterol antagonist
0,078  0,046  Adenosine A3 receptor antagonist
0,162  0,131  Antineoplastic (lymphoma)
0,036  0,006  Complement factor 1r inhibitor
0,149  0,118  P-glycoprotein inhibitor
0,144  0,114  Antineoplastic (gastric cancer)
0,052  0,022  Leukocyte elastase inhibitor
0,156  0,126  Antiparasitic
0,083  0,054  Caspase 7 inhibitor
0,108  0,079  Caspase 3 inhibitor
0,062  0,033  Nicotinic neuronal receptor agonist
0,074  0,045  Peroxisome proliferator-activated receptor gamma antagonist
0,082  0,054  Phosphodiesterase 11A inhibitor
0,082  0,054  Phosphodiesterase XI inhibitor
0,162  0,136  VEGF expression inhibitor
0,090  0,063  Hepatocyte growth factor antagonist
0,095  0,071  Carcinogenic, group 2B
0,134  0,112  Dual specificity phosphatase 3 inhibitor
0,114  0,092  Sodium channel blocker
0,135  0,114  Diabetic retinopathy treatment
0,168  0,147  Spasmolytic
0,123  0,103  Antianemic
0,060  0,041  Potassium channel (Ca-activated) blocker
0,085  0,065  Bromodomain-containing protein 2 inhibitor
0,087  0,068  Glutamate release inhibitor
0,153  0,134  Neurotrophic factor enhancer
0,057  0,039  Postcoital contraceptive
0,066  0,048  Antihemophilic
0,194  0,177  Angiogenesis inhibitor
0,063  0,046  Transcription factor RelA inhibitor
0,036  0,019  Melatonin receptor 1A agonist
0,097  0,081  DOPA decarboxylase inhibitor
0,053  0,037  Alpha tubulin antagonist
0,129  0,114  Protein kinase (CK1) gamma 3 inhibitor
0,143  0,129  UGT1A1 substrate
0,018  0,006  Melatonin receptor 1A antagonist
0,198  0,188  GST A substrate
0,051  0,041  Alpha 1L adrenoreceptor antagonist
0,108  0,099  Sodium channel (voltage-gated) blocker
0,066  0,057  Benzodiazepine agonist
0,057  0,049  Ryanodine receptor antagonist
0,155  0,148  UGT1A6 substrate
0,031  0,025  Melatonin agonist
0,048  0,042  Anesthetic inhalation
0,025  0,019  Complement factor 1s inhibitor
0,170  0,165  Proliferative diseases treatment
0,200  0,195  Antiprotozoal (Plasmodium)
0,215  0,212  Antibacterial
0,128  0,124  LIM domain kinase 1 inhibitor
0,124  0,121  Antihelmintic (Nematodes)
0,086  0,084  UGT2B11 substrate
0,067  0,065  Topoisomerase II alpha inhibitor
0,158  0,156  Antioxidant
0,117  0,115  Antiviral (Herpes)
0,152  0,151  Antineoplastic enhancer
0,089  0,088  EphA2 antagonist
0,107  0,105  Alkaline phosphatase inhibitor
0,144  0,142  Dyrk kinase inhibitor
0,058  0,058  Acetylcholine M5 receptor agonist
0,040  0,040  Dihydrofolate reductase inhibitor

